Skip to main content
. 2023 Feb 8;53(3):337–352. doi: 10.1111/cea.14276

FIGURE 2.

FIGURE 2

Prevalence of current eczema symptoms over time in adolescents (A) and children (B) for GAN Phase I centres participating in at least one of ISAAC Phase I and III (coloured lines) with additional mean trend of ISAAC‐only centres participating in both Phases I and III (black line).